Медицинская литература. Новинки

 

 

 

 

 

 

ФЕНОМЕН МАКРОТИРОТРОПИНЕМИИ В СОВРЕМЕННОЙ КЛИНИЧЕСКОЙ ПРАКТИКЕ

Вы можете загрузить полный текст статьи в формате pdf

Ключевые слова:

Литература:
1. Melmed S., Casanueva F.F., Hoffman A.R. et al. Diagnosis and
treatment of hyperprolactinemia: an endocrine society clinical
practice guideline. J. Clin. Endocr. Metab. 2011; 96: 273–288.
2. Gibney J., Smith P., McKenna T.J. The impact on clinical practice
of routine screening for macroprolactin. J. Clin. Endocr. Metab.
2005; 90: 3927–3932.
3. Amadori P., Dilberis C., Marcolla A. All the studies on hyperprolactinemia should not forget to consider the possible presence of
macroprolactinemia. Eur. J. Endocr. 2004; 150: 93–94.
4. Hattori N. Macroprolactinemia: a new cause of hyperprolactinemia. J. Pharmacol. Sci. 2003; 92: 171–177.
5. Ismail A.A., Walker P.L., Barth J.H. et al. Wrong Biochemistry
Results: Two Case Reports and Observational Study in 5310
Patients on Potentially Misleading Thyroid-stimulating Hormone
and Gonadotropin Immunoassay Results. Clin. Chem. 2002; 48:
2023–2029.
6. Vieira J.G., Nishida S.K., Faria de Camargo M.T. et al.
“MacroLH”: anomalous molecular form that behaves as a complex of luteinizing hormone (LH) and IgG in a patient with unexpectedly high LH values. Clin. Chem. 2003; 49: 2104–2105.
7. Halsall D.J., Barker P., Prentice A. et al. MacroFSH: elevated
serum follicular stimulating hormone (FSH) due to an FSH-IgG
complex. Clin. Chim. Acta. 2005; 355: 272.
8. Kricka L.J. Interference in immunoassays - still a threat. Clin.
Chem. 2000; 46: 1037–1038.
9. Ismail A., Barth J.H. Wrong biochemistry results. Br. Med. J. 2001;
323: 705–706.
10. Lazarus J.H., John R., Ginsberg J. et al. Transient neonatal hyperthyrotrophinaemia: a serum abnormality due to transplacentally
acquired antibody to thyroid stimulating hormone. Br. Med. J.
1983; 286: 592–594.
11. Tamaki H., Takeoka K., Nishi I. et al. Novel thyrotropin (TSH)-TSH antibody complex in a healthy woman and her neonates.
Thyroid. 1995; 5: 299–303.
12. Newman J.D., Bergman P.B., Doery J.C., Balazs N.D. Factitious
increase in thyrotropin in a neonate caused by a maternally transmitted interfering substance. Clin. Chem. 2006; 52: 541–542.
13. Halsall D.J., FahieWilson M.N., Hall S.K. et al. Macro thyrotropin-IgG complex causes factitious increases in thyroid-stimulating hormone screening tests in a neonate and mother. Clin.
Chem. 2006; 52: 1968–1969.
14. Sakai H., Fukuda G., Suzuki N. et al. Falsely elevated thyroid-stimulating hormone (TSH) level due to macro-TSH. Endocr. J. 2009;
56: 435–440

Makro-thyrotropinemia in clinical practic

Keywords: